Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-07-10 04:00 | 2014-07-07 | ICPT | N/A | TALLARIGO LORENZO | Director | Other | OPT+S | $243.06 | 2,000 | $486,110 | 0 | -100.0% |
| 2014-02-12 05:02 | 2014-02-10 | ICPT | N/A | TALLARIGO LORENZO | Director, 10% owner | Other | OPT+S | $354.52 | 368 | $130,463 | 1,640 | -18.3% |
| 2014-01-10 05:30 | 2014-01-07 | ICPT | N/A | TALLARIGO LORENZO | Director, 10% owner | Other | SALE | $67.41 | 1,839 | $123,967 | 1,640 | -52.9% |
| 2013-10-24 04:31 | 2013-10-21 | ICPT | N/A | TALLARIGO LORENZO | Director, 10% owner | Other | SALE | $62.50 | 124,912 | $7,807,000 | 5,938,890 | -2.1% |
| 2013-10-18 04:33 | 2013-10-15 | ICPT | N/A | TALLARIGO LORENZO | Director, 10% owner | Other | SALE | $62.50 | 1,123,415 | $70,213,438 | 6,063,802 | -15.6% |
| 2008-02-29 00:09 | 2008-02-26 | LLY | ELI LILLY & Co | TALLARIGO LORENZO | Officer; President, Internat'l Opers. | Pharmaceutical Preparations | SALE | $51.50 | 10,000 | $515,000 | 76,105 | -11.6% |
| 2007-09-04 23:59 | 2007-09-04 | LLY | ELI LILLY & Co | TALLARIGO LORENZO | Officer; President, Internat'l Opers. | Pharmaceutical Preparations | SALE | $57.73 | 4,533 | $261,707 | 70,525 | -6.0% |
| 2007-06-04 23:02 | 2007-06-01 | LLY | ELI LILLY & Co | TALLARIGO LORENZO | Officer; President, Internat'l Opers. | Pharmaceutical Preparations | SALE | $58.73 | 4,533 | $266,223 | 75,058 | -5.7% |
| 2007-04-09 20:40 | 2007-04-04 | LLY | ELI LILLY & Co | TALLARIGO LORENZO | Officer; President, Internat'l Opers. | Pharmaceutical Preparations | SALE | $55.00 | 4,533 | $249,315 | 79,591 | -5.4% |
| 2006-10-24 18:40 | 2006-10-20 | LLY | ELI LILLY & Co | TALLARIGO LORENZO | Officer; President, Internat'l Opers. | Pharmaceutical Preparations | SALE | $56.96 | 5,814 | $331,162 | 68,313 | -7.8% |
| 2005-03-04 01:24 | 2005-02-03 | LLY | ELI LILLY & Co | TALLARIGO LORENZO | Officer; President, Internat'l Opers. | Pharmaceutical Preparations | OPT+S | $55.54 | 4,000 | $222,160 | 54,299 | -6.9% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.